Non-adherence to medication remains one of the major barriers to the management of schizophrenia 2, 3 Estimates on non-adherence to antipsychotic treatments range from 40 to 90% [4] [5] [6] [7] Non-and partial adherence contributes to relapse, hospitalization and poor patient outcomes 8 -~ 80% of patients relapse within a year after antipsychotic medication non-adherence 9 Relapse of psychosis is the leading cause of hospitalization for patients with Schizophrenia
The largest direct cost of Schizophrenia is hospitalizations 10 * More than three-quarters of direct costs associated with Schizophrenia are due to frequent and prolonged hospitalization or residential care 11, 12 Long-acting injectable antipsychotics may play an important role in reducing the risk of relapse by promoting treatment adherence (10) The substantial savings accruing to the hospital and the healthcare system provide a strong economic rationale for use of RLAI treatment in patients with Schizophrenia
Discussion
The reduction in hospitalization with RLAI treatment seen in this study is consistent with results from other studies 13, 14, 15 The economic impact of RLAI treatment observed in this study provides additional evidence to support cost-effectiveness analyses which have demonstrated the economic benefits of RLAI treatment 16, 17, 18 Numerous other costs associated with relapse were not evaluated: 11 -human costs of relapse (patient and family stress) -job losses for the patient -productivity losses of family members -cost of illness to society -cost of police services associated with acute psychosis
In addition, the improvement in wait time in the ER was not evaluated Limitations This retrospective chart review was conducted at a single institution and focused on a single treatment strategy -use of RLAI This study was limited to an assessment of hospital and medication costs for second-generation oral antipsychotic therapy compared with RLAI
The patient sample was small and the study duration was relatively short for Schizophrenia, a chronic and often progressive condition
